Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Thorac Surg ; 103(3): e267-e270, 2017 Mar.
Article in English | MEDLINE | ID: mdl-28219566

ABSTRACT

Immunoglobulin G4 (IgG4)-related sclerosing disease is a recently proposed systemic fibroinflammatory disease entity, with periaortitis as a representative manifestation in the cardiovascular system. We present a case of IgG4-related periaortitis involving the aortic arch and proximal great vessels, mimicking an anterior mediastinal tumor on computed tomography. In patients with a soft tissue mass along the aortic wall, IgG4-related periaortitis should be included as a differential diagnosis and timely serologic investigation should be performed to prevent unnecessary surgery, because the disease shows a remarkable response to corticosteroids.


Subject(s)
Aorta, Thoracic/pathology , Aortitis/pathology , Immunoglobulin G/blood , Mediastinal Neoplasms/pathology , Aorta, Thoracic/diagnostic imaging , Aortitis/diagnostic imaging , Humans , Male , Mediastinal Neoplasms/diagnostic imaging , Middle Aged , Tomography, X-Ray Computed
2.
J Neurol Sci ; 294(1-2): 112-8, 2010 Jul 15.
Article in English | MEDLINE | ID: mdl-20441994

ABSTRACT

Glioblastoma (GBM) is a malignant CNS neoplasm. The prognosis of GBM may be influenced by the molecules of p53/MDM2/p14ARF, RB/p16INK4a, and the EGFR/PTEN/protein kinase B (PKB)/phosphoinositide 3-kinase (PI3K) pathways. We studied the expression status of specific molecular markers in GBMs by immunohistochemistry (IHC) and FISH in correlation with the clinical outcomes. The positivity of EGFR FISH and those of EGFR IHC by pharmDx and Zymed antibodies were 64.9%, 73.5%, and 43.4%, respectively. EGFR pharmDx antibody was more sensitive but less specific than EGFR Zymed antibody. p53 overexpression, MDM2 expression, p16 loss, PTEN loss, PKB and PI3K expression were found in 48.2%, 26.5%, 56.6%, 21.4%, 15.7% and 6.0%, respectively. EGFR IHC and FISH significantly, although not completely, correlated and EGFR and p53 immunoexpression also showed positive correlation. On multivariate survival studies, old age (> or =40 yrs) and bilaterality were independent unfavorable prognosis factors (p<0.05). Stratified by age, resectability and tumor size <5 cm were favorable survival factors in young (40 or =40 yrs), respectively. Furthermore, the patients with supratentorial tumor lived longer than the patients with infratentorial tumor (p<0.05). Longer survival (survival length, > or =3 years) was statistically less frequent in the patients in the EGFR FISH-positive group (p=0.031).


Subject(s)
Brain Neoplasms/metabolism , Glioblastoma/metabolism , Adult , Age Factors , Brain/metabolism , Brain/surgery , Brain Neoplasms/diagnosis , Brain Neoplasms/mortality , Brain Neoplasms/pathology , ErbB Receptors/metabolism , Female , Glioblastoma/diagnosis , Glioblastoma/mortality , Glioblastoma/pathology , Humans , Immunohistochemistry , In Situ Hybridization, Fluorescence , Infratentorial Neoplasms/diagnosis , Infratentorial Neoplasms/metabolism , Infratentorial Neoplasms/mortality , Infratentorial Neoplasms/pathology , Male , PTEN Phosphohydrolase/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Prognosis , Proto-Oncogene Proteins c-akt/metabolism , Supratentorial Neoplasms/diagnosis , Supratentorial Neoplasms/metabolism , Supratentorial Neoplasms/mortality , Supratentorial Neoplasms/pathology , Survival Analysis , Tumor Suppressor Protein p53/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...